home / stock / drug:cc / drug:cc news

DRUG:CC News and Press, Bright Minds Biosciences Inc. From 05/02/22

Stock Information
Company Name: Bright Minds Biosciences Inc.
Stock Symbol: DRUG:CC
Market: CNQC
Website: brightmindsbio.com
Menu
DRUG:CC DRUG:CC Quote DRUG:CC Short DRUG:CC News DRUG:CC Articles DRUG:CC Message Board
Get DRUG:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DRUG:CC - Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

-- Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of clinical and research expertise in psychiatry, addiction, behavioral health, and pharmacology to guide Company’s development program...
DRUG:CC - Bright Minds Biosciences to Host Symposium on Therapeutic Developments within Dravet Syndrome and Featuring a Panel with Key Opinion Leaders

-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Conference call to be held on May 19, 2022, 10:00am ET -- VANCOUVER, British Columbia, April 19, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Com...

Previous 10 Next 10